Wheeler Bio Closes Financing Round to Support Oklahoma City Facility
Wheeler Bio’s primary service offering, Portable CMC™, is an open source chemistry, manufacturing, and controls middleware.
Source: genengnews.com
Synthace Experiment Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Synthace Experiment Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Synthace Experiment Platform Today - Breaking & Trending Today
Wheeler Bio Announces Closing Of 31 Million Series A Round Supporting Its Clinical (CGMP) Drug Substance Manufacturing Facility In Oklahoma City
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP...
Source: pharmaceuticalonline.com
Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City
/PRNewswire/ -- Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch...
Source: prnewswire.com
Wheeler Bio's $31M In Financing To Support Clinical Drug Substance Mfg. Facility
To build a disruptive CDMO model aimed at changing the paradigm for the gene-to-IND supply chain.
Source: contractpharma.com